PANACEA BIOTEC
|
The Current P/E Ratio of PANACEA BIOTEC is 224.20.
Share Price | ₹406.7 | Sep 05,2025 |
Market Cap | ₹2,493.1 Cr | |
Earnings-TTM | ₹11.1 Cr | TTM-Consolidated Results |
Price/Earnings | 224.20x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of PANACEA BIOTEC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,493.1 Cr] as on Sep 05,2025
(/) Earnings [ ₹11.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 224.20x ]
Thus, for PANACEA BIOTEC , the investors are currently willing to pay 224.20 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PANACEA BIOTEC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PANACEA BIOTEC over the last five years.
Historical PE (Price/Earnings) ratio chart of PANACEA BIOTEC
PE Ratio Performance Analysis for PANACEA BIOTEC
- PANACEA BIOTEC 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.17x.
- PANACEA BIOTEC 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PANACEA BIOTEC 's p/e ratio peaked in Mar2022 at 0.84x.
- PANACEA BIOTEC 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does PANACEA BIOTEC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
PANACEA BIOTEC | 11.12 | 224.20 | 2,493.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 36.75 | 382,622.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 69.18 | 159,536.0 |
CIPLA LTD | 5,406.81 | 23.21 | 125,468.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.52 | 121,162.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.49 | 105,874.0 |
MANKIND PHARMA LTD | 1,905.51 | 55.27 | 105,315.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.00 | 102,047.0 |
LUPIN LTD | 3,722.18 | 23.86 | 88,822.8 |
AUROBINDO PHARMA LTD | 3,417.93 | 17.75 | 60,658.9 |
ABBOTT INDIA LTD | 1,452.29 | 45.62 | 66,253.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PANACEA BIOTEC 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.75x |
Max industry PE | 224.20x |
Median industry PE | 36.75x |
Average industry PE | 54.26x |
You may also like the below Video Courses